Mandate

Vinge has advised SBB and Sveafastigheter in connection with an exchange offer

July 09, 2024 Banking and Finance

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (SBB) and Sveafastigheter AB in connection with an exchange offer directed to investors in SBB’s outstanding bonds, whereby investors exchanged senior and hybrid bonds in SBB for new senior bonds issued in Sveafastigheter AB. The existing bonds were partly issued under SBB’s EMTN programme, partly on a standalone basis. Following the transaction, the investors have been slotted in under Swedish bond terms on a standalone basis.

As a result of the transaction, outstanding bonds in SBB in aggregate amounts of EUR 275,039,000, SEK 721,000,000 and NOK 40,000,000 were exchanged for new bonds in Sveafastigheter amounting to EUR 110,900,000 (under a framework of EUR 183,500,000) and SEK 412,500,000. In addition to the instrument exchange, SBB also offered, under certain conditions, a cash component as compensation for the exchange.

Danske Bank A/S, DNB Markets, part of DNB Bank ASA, Sweden branch and Skandinaviska Enskilda Banken AB (publ) acted as dealer managers in connection with the exchange offer.

Vinge's team consisted of Mikael Ståhl, Rikard Lindahl, Lionardo Ojeda, William Kåge, Benjamin Vafaeian, August Ahlin and Filip Magnusson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025